Back
Palantir Technologies Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
89
PLTR
Palantir Technologies
Last Price:
36.84
Seasonality Move:
-8.5%
Sell
14
ITCI
Intra-Cellular Therapies
Last Price:
73.33
Seasonality Move:
39.33%
Buy
89
Palantir Technologies (PLTR)
is a Buy
Is Palantir Technologies a Buy, Sell or Hold?
- The current Palantir Technologies [PLTR] share price is $37.10. The Score for PLTR is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- PLTR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
14
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.21. The Score for ITCI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PLTR Stock Price Chart
What is Palantir Technologies's stock price today?
-
The Palantir Technologies share price today is $37.10
The current trend is moderately bullish and PLTR is experiencing slight buying pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
PLTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.87 | Buy |
Relative Strength Index (14 RSI): | 70.48 | Buy |
Chaikin Money Flow: | 9124865 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.09 - 36.65) | Buy |
Bollinger Bands (100): | (22.67 - 32.39) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 42.52 | Sell |
Chaikin Money Flow: | -234523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.04 - 75.68) | Sell |
Bollinger Bands (100): | (68.39 - 76.99) | Buy |
PLTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.99 | Buy |
20-day SMA: | 34.55 | Buy |
50-day SMA: | 31.21 | Buy |
200-day SMA: | 24.28 | Buy |
8-day EMA: | 36.73 | Buy |
20-day EMA: | 35.04 | Buy |
50-day EMA: | 31.97 | Buy |
200-day EMA: | 25.28 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.4 | Sell |
20-day SMA: | 74.45 | Sell |
50-day SMA: | 75.51 | Sell |
200-day SMA: | 70.84 | Buy |
8-day EMA: | 74.91 | Sell |
20-day EMA: | 74.89 | Sell |
50-day EMA: | 74.57 | Sell |
200-day EMA: | 70.13 | Buy |
Palantir Technologies Earnings Growth & PLTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.08 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Palantir Technologies Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |